Dark Forest Capital Management’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
Other funds holding SRPT
RCM
EAM
Dark Forest Capital Management's SRPT Position: Q1 2026 in Review
Dark Forest Capital Management sold out of Sarepta Therapeutics (SRPT) in Q1 2026, closing a stake of 28,780 shares — an estimated $619K sold.
Dark Forest Capital Management first reported a position in SRPT in Q3 2021 and held it in 13 quarters. The position peaked at $3.41M in Q2 2025. 344 funds tracked by Wall St. Rank hold SRPT as of Q1 2026.
- Dark Forest Capital Management reported no remaining Sarepta Therapeutics position as of Q1 2026 after selling out during the quarter.
- Dark Forest Capital Management sold 28,780 Sarepta Therapeutics shares in Q1 2026, an estimated $619K.
- Dark Forest Capital Management first reported a position in Sarepta Therapeutics in Q3 2021 and held it in 13 quarters.
- Dark Forest Capital Management's Sarepta Therapeutics position peaked at $3.41M in Q2 2025.
- 344 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q1 2026.
Based on Dark Forest Capital Management's 13F filing for Q1 2026, filed 15 May 2026.